Finding Organics on Mars Isn't Enough. ExoMars Will Look for Their "Handedness. "

We’ve known for a long time that there are organic molecules on Mars. Rovers and landers keep turning them up wherever they look. The science-journalism coverage adds useful context, while the strongest evidential footing still comes from the underlying data, papers or institutional documentation.

This matters because biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. But there is one feature of organic molecules that can point very strongly in the direction of life or not - its chirality, and a new instrument on the Rosalind Franklin rover. We’ve actually sent a chirality tester to Mars before - the Sample Analysis at Mars instrument onboard Curiosity is capable of measuring chirality.

Other rovers, such as Perseverance, have likely found such complex organic molecules (such as the famous “leopard spots” we reported on previously), but the operators of that. Since that program has been cut by NASA due to funding constraints, the answer to whether there is (or was) life on Mars might continue to sit in a sample capsule on the red.

They plan to equip the Rosalind Franklin rover to do all the science it needs to on site without relying on expensive sample return missions. One critical instrument to complete that mission is the Mars Organic Molecule Analyzer (MOMA).

The Murchison meteorite is a pristine sample of a carbonaceous chondrite that crashed into Australia in 1969. Given that the research team had originally expected to find an imbalance due to biological contamination from Earth’s native microbes, that came as quite a surprise.

The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.

But after some consideration, they think the meteorite actually picked up traces of burnt fossil fuels containing pristane and phytane while coming in through Earth’s atmosphere. Now we’ll only have to wait another 10 years or so before one of the most important instruments we will have ever sent to Mars really gets to work.

Because this item comes through Universe Today as science journalism, it should be treated as contextual reporting rather than primary evidence. Good science reporting can identify why a result matters, connect it to the wider literature and make technical work readable, but the decisive evidence remains in the original paper, dataset, mission release or technical record. That distinction is especially important when a story is later repeated by aggregators, because repetition increases visibility, not evidential strength.

The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Source